Cardiovascular‑disease‑related pharmaceutical development creates
consistent market demand for biological thrombolysis raw material, pushing drug
manufacturers to hunt for a reliable Urokinase API Supplier. Urokinase API
isolated from human urine is widely applied for researching and producing
thrombolytic injectable preparations. Key quality metrics contain specific
activity, impurity protein content, endotoxin and virus safety profile.
Many purchasing teams suffer practical pain points: large fluctuation of
specific‑activity index, insufficient virus safety validation data and lack of
complete audit documents. Selecting a trusted Urokinase API Supplier helps you
avoid these hidden risks in downstream drug development.
Kangyuan serves as a professional Urokinase API Supplier based in Qingdao,
China. We maintain complete in‑house production workflow: raw‑material handling,
multi‑stage purification, virus inactivation and finished‑product release
testing. Each batch is strictly examined for specific activity, foreign‑protein
residues, endotoxin and microbial indicators. We support trial‑order sample
supply and large‑volume commercial bulk delivery.
We provide COA, MSDS, virus validation reports and other technical
materials for customers’ global registration and factory audit. Our technical
team answers questions regarding product storage, handling and formulation
application. Send an inquiry to Kangyuan if you need stable urokinase API source
for your thrombolytic drug projects.